Inogen | INGN - Stock


Inogen reported $25.08M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Accuray USD 150.96M 4.54M Dec/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 97.99M 5.57M Mar/2026
AtriCure USD 81.14M 2.65M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Chart Industries USD 587.5M 15.2M Mar/2026
Cooper Companies USD 846M 35M Sep/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Globus Medical USD 772.6M 13.32M Mar/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 462.5M 9.9M Mar/2026
Masimo USD 400M 61.4M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Orthofix International USD 177.82M 5.5M Mar/2026
Philips EUR 2.87B 390M Dec/2025
ResMed USD 911.88M 10.17M Mar/2026
Steris USD 673.5M 15M Dec/2025
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026